Genotype influences in vivo dopamine transporter availability in human striatum

Neuropsychopharmacology

Volumn 22, Issue 2, 2000, Pages 133-139

  Heinz, Andreas ^a,b   Goldman, David ^a,b   Jones, Douglas W ^a,b   Palmour, Roberta ^a,b   Hommer, Dan ^a,b   Gorey, Julia G ^a,b   Lee, Kan S ^a,b   Linnoila, Markku ^a,b   Weinberger, Daniel R ^a,b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b DICBR   (United States)

Author keywords

CIT; Alcoholism; Dopamine transporter; Gene expression; SLC6A3; SPECT

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; DOPAMINE TRANSPORTER; IODINE 123;

ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; ALLELE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN EXPERIMENT; ISOTOPE LABELING; MALE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BINDING; RNA TRANSLATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

3' UNTRANSLATED REGIONS; ADULT; ALCOHOLISM; CARRIER PROTEINS; COCAINE; CORPUS STRIATUM; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; GENOTYPE; HOMOZYGOTE; HUMANS; IODINE RADIOISOTOPES; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MINISATELLITE REPEATS; NERVE TISSUE PROTEINS; POLYMORPHISM, GENETIC; REFERENCE VALUES; TEMPERANCE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0034142232     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(99)00099-8     Document Type: Article

References (51)

1. American Psychiatric Association (1992): Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. Washington, DC, American Psychiatric Press
2. Andreasen NC (1982): Negative symptoms in schizophrenia: Definition and reliability. Arch Gen Psychiatry 39:784-788
3. 123I]β-CIT) in non-human primates: Pharmacokinetics, biodistribution and SPECT brain imaging coregistered with MRI. Nucl Med Biol 5:597-606
4. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961): An inventory for measuring depression. Arch Gen Psychiatry 4:561-571
5. Caron MG (1996): Images in neuroscience. Molecular biology. II. A dopamine transporter mouse knockout. Am J Psychiatry 153:1515
6. Chapman LJ, Chapman JP, Numbers JF, Edell WS, Carpenter BN, Beckfield D (1984): Impulsive nonconformity as a trait contributing to the prediction of psychoticlike and schizotypal symptoms. J Nerv Mental Dis 172:681-691
7. Cloninger CR (1987): Neurogenetic adaptive mechanisms in alcoholism. Science 236:410-416
8. Cloninger CR (1995): The psychobiological regulation of social cooperation. Nature Med 1:623-624
9. Cook EH Jr, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, Leventhal BL (1995): Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 56:993-998
10. Farde L, Halldin C, Mueller L, Suhara T, Karlsson P, Hall H (1994): PET study of [C-11]β-CIT binding to monoamine transporters in the monkey and human brain. Synapse 16:93-103
11. Faraone SV, Biederman J (1998): Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiatry 44:951-958
12. Fils-Aime ML, Eckhardt MJ, George DT, Brown GL, Mefford I, Linnoila M (1996): Early-onset alcoholics have lower cerebrospinal fluid 5-hydroxyindolacetic acid levels than late-onset alcoholics. Arch Gen Psychiatry 53:211-216
13. Franke P, Schwab SG, Knapp M, Gansicke M, Delmo C, Zill P, Trixler M, Lichtermann D, Hallmayer J, Wildenauer DB, Maier W (1999): DAT1 gene polymorphism in alcoholism: A family-based association study. Biol Psychiatry 45:652-654
14. Gelernter J, Kranzler HR, Satel SL, Rao PA (1994): Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmacology 11:195-200
15. Goldman D (1995a): Identifying alcoholism vulnerability alleles. Alc Clin Exp Res 19:824-831
16. Goldman D (1995b): Candidate genes in alcoholism. Clin Neurosci 3:174-181
17. Hamilton M (1960): A rating scale for depression. J Neurol Neurosurg Psychiatry 223:1-8
18. Heinz A, Lichtenberg-Kraag B, Sällström Baum S, Gräf K, Krüger F, Dettling M, Rommelspacher H (1995): Evidence for prolonged recovery of dopaminergic transmission in alcoholics with poor treatment outcome. J Neural Transm 2:149-158
19. Heinz A, Dufeu P, Kuhn S, Dettling M, Graef KJ, Kuerten I, Rommelspacher H, Schmidt LG (1996a): Psychopathological and behavioral correlates of dopaminergic sensitivity in alcohol-dependent patients. Arch Gen Psychiatry 53:1123-1128
20. Heinz A, Schmidt K, Sällström Baum S, Kuhn S, Dufeu P, Schmidt LG, Rommelspacher H (1996b): Influence of dopaminergic transmission on severity of withdrawal syndrome in alcoholism. J Stud Alcohol 57:471-474
21. Heinz A, Ragan P, Jones DW, Hommer D, Williams W, Knable MB, Gorey JG, Doty L, Geyer C, Lee KS, Coppola R, Weinberger DR, Linnoila M (1998): Reduced serotonin transporters in alcoholism. Am J Psychiatry 155:1023-1028
22. Heinz A, Saunders RC, Kolachana BS, Bertolino A, Jones DW, Gorey JG, Bachevalier J, Lee KS, Knable MB, Saunders RC, Weinberger DR (1999): Disinhibition of subcortical dopaminergic neurotransmission in rhesus monkeys with neonatal mesial temporal lesions. Synapse 39:71-79
23. Hollingshead AB (1973): Four Factor Index of Social Skills. New Haven, CT, Yale University
24. Imperato A, Di Chiara G (1986): Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J Pharmacol Exp Ther 239:219-228
25. Jones DW, Heinz A, Gorey JG, Lee KS, Knable MB, Urbina RA, Weinberger DR (1997): A simple, sensitive and efficient method of directly determining plasma concentrations of free [I-123]β-CIT at extended times by TLC of ultrafiltrates. J Nucl Med 38(Suppl):287P
26. Koob GF (1996): Drug addiction: The yin and yang of hedonic homeostasis. Neuron 16:893-896
27. Laine TP, Ahonen A, Torniainen P, Heikkilä J, Pyhtinen J, Räsänen P, Niemelä O, Hillborn M (1999): Dopamine transporters increase in human brain after alcohol withdrawal. Mol Psychiatry 4:189-191
28. Laruelle M, Baldwin RM, Malison RT, Zea-Ponce Y, Zoghbi SS, Al-Tikriti MS, Sybirska EH, Zimmermann RC, Wisniewski G, Neumeyer JL, Milius RA, Wang S, Smith EO, Roth RH, Charney DS, Hoffer PB, Innis RB (1993): SPECT imaging of dopamine and serotonin transporters with [123-I]β-CIT: Pharmacological characterization of brain uptake in non-human primates. Synapse 13: 295-309
29. Laruelle M, Wallace A, Seibyl JP, Baldwin RM, Zea-Ponce Y, Zoghbi SS, Neumeyer JL, Charney DS, Hoffer PB, Innis RB (1994): Graphical, kinetic, and equilibrium analyses of in vivo [123-I]β-CIT binding to dopamine transporters in healthy human subjects. J Cerebr Blood Flow Metab 14:982-994
30. Mash DC, Staley JK, Doepel FM, Yound SN, Ervin FR, Palmour RM (1996): Altered dopamine transporter densities in alcohol-preferring vervet monkeys. NeuroReport 7:457-462
31. Mereu G, Fadda F, Gessa GL (1984): Ethanol stimulates the firing rate of nigral dopaminergic neurons in unanesthetized rats. Brain Res 292:63-69
32. Miller SA, Dykes DD, Plesky HF (1988): A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
33. Parsian A, Zhang ZH (1997): Human dopamine transporter gene polymorphism (VNTR) and alcoholism. Am J Med Genet 74:480-482
34. Robinson TE, Berridge KC (1993): The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res Rev 18:247-291
35. Rossetti ZL, Melis F, Carboni S, Diana M, Gessa GL (1992): Alcohol withdrawal in rats is associated with a marked fall in extraneural dopamine. Alc Clin Exp Res 16:529-532
36. Sabol SZ, Nelson ML, Fisher C, Gunzerath L, Brody CL, Hu S, Sirota LA, Marcus SE, Greenberg BD, Lucas FR, IV, Benjamin J, Murphy DL, Hamer DH (1999): A genetic association for cigarette smoking behavior. Health Psychol 18:7-13
37. Sander T, Harms H, Podschus J, Finckh U, Nickel B, Rolfs A, Rommelspacher H, Schmidt LG (1997): Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biol Psychiatry 41:299-304
38. Sano A, Kondoh K, Katimoto Y, Kondo I (1993): A 40-nucleotide repeat polymorphism in the human dopamine transporter gene. Hum Genet 91:405-406
39. Schmidt LG, Harms H, Kuhn S, Rommelspacher H, Sander T (1998): Modification of alcohol withdrawal by the A9 allele of the dopamine transporter gene. Am J Psychiatry 155:474-478
40. Schulteis G, Koob G (1994): Neuropharmacology: Dark side of drug dependence. Nature 371:108-109
41. Seibyl JP, Wallace E, Smith EO, Stabin M, Baldwin RM, Zoghbi S, Zea-Ponce Y, Gao Y, Zhang WY, Neumeyer JL, Zubal IG, Charney DS, Hoffer PB, Innis RB (1994): Whole-body biodistribution, radiation absorbed dose and brain SPECT imaging with Iodine-123-β-CIT in healthy human subjects. J Nucl Med 35:764-770
42. Selzer ML (1971):The Michigan alcoholism screening test: The quest for a new diagnostic instrument. Am J Psychiatry 127:1653-1658
43. Spielberger CD, Gorsuch RL, Lushene RD (1970): STAI Manual. Palo Alto, CA, Consulting Psychologists Press
44. Spitzer R, Williams J, Gibbon M, First M (1990a): Structured Clinical Interview for DSM-III-R-Patient Edition (with Psychotic Screen) (SCID I, Version 1.0). Washington, DC, American Psychiatric Press
45. Spitzer RL, Williams JBW, Gibbon M, First MB (1990b): Structured Clinical Interview for DSM-III-R -Personality Disorders (SCID II, Version 1.0). Washington, DC, American Psychiatric Press
46. Tiihonen J, Kuikka J, Begström K, Hakola P, Karhu J, Ryynänen OP, Föhr J (1995): Altered striatal dopamine re-uptake sites in habitually violent and non-violent alcoholics. Nature Med 1:654-657
47. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, Uhl GR (1992): Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14:1104-1106
48. Volkow ND, Wang G, Fowler JS, Logan J, Hitzeman R, Ding YS, Pappas N, Shea C, Piscani K (1996): Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alc Clin Exp Res 20:1594-1598
49. Waldman ID, Rowe DC, Abramowitz A, Kozel ST, Mohr JH, Sherman SL, Cleveland HH, Sanders ML, Gard JMC, Stever C (1998): Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: Heterogeneity owing to diagnostic subtype and severity. Am J Hum Genet 63:1767-1776
50. Wise RA (1988): The neurobiology of craving: Implications for the understanding and treatment of addiction. J Abn Psychol 97:118-132
51. Zametkin AJ, Ernst M (1999): Problems in the management of attention-deficit-hyperactivity disorder. New Eng J Med 340:40-46